Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSO-TOP study of Daivobet/Dovobet Gel with versus without the Topical Treatment Optimising Programme in mild to moderate plaque psoriasis
NL-OMON37524Phase 4Active, not recruiting
- Sponsor
- SciDerm
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of calcipotriol + betamethasone in plaque psoriasis and psoriasis (2 arms), sponsored by SciDerm. Primary endpoint: PGA response at week 8. Started Aug 2012; status: active, not recruiting.
02
Drugs
calcipotriol + betamethasone
03
Conditions
plaque psoriasispsoriasis
Beyond the preview
Go deeper on NL-OMON37524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37524.